Breakthrough pneumonia, meningitis and bloodstream infection due to Streptococcus pneumoniae during cefixime therapy
Novella Carannante1, Carlo Pallotto1, Mariano Bernardo2
1First Division of Infectious Diseases, Cotugno Hospital, AORN dei Colli , Naples , Italy.
Abstract:
Streptococcus pneumoniae is the main pathogen in invasive, life-threatening diseases such as bacteremia, meningitis, and pneumonia. We describe three cases of breakthrough pneumococcal severe life-threatening infections, including two meningitis and one bloodstream infection in patients treated with cefixime for otitis, sinusitis and pneumonia, respectively. Cefixime does not seem to be fully effective in treating invasive pneumococcal diseases. Because penicillin non-susceptibility might be linked to cefixime failure, the prompt knowledge of susceptibility to penicillin in S. pneumoniae might be very useful. Furthermore, MIC of cefixime should be measured because values >0.5 mg/L might be related to failure.
Insights
Cefixime may not effectively treat severe invasive pneumococcal infections. Penicillin susceptibility testing and cefixime Minimum Inhibitory Concentration (MIC) are crucial for guiding treatment of Streptococcus pneumoniae infections.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Streptococcus pneumoniae is a primary cause of severe infections like meningitis and pneumonia.
- Invasive pneumococcal diseases (IPDs) pose significant life-threatening risks.
Observation:
- Three cases of breakthrough severe IPDs (two meningitis, one bloodstream infection) occurred in patients treated with cefixime.
- Patients had underlying conditions including otitis, sinusitis, and pneumonia.
Findings:
- Cefixime demonstrated limited efficacy in treating these invasive pneumococcal infections.
- Penicillin non-susceptibility in S. pneumoniae may correlate with cefixime treatment failure.
- Cefixime MIC values above 0.5 mg/L were associated with treatment failure.
Implications:
- Prompt penicillin susceptibility testing is vital for managing S. pneumoniae infections.
- Measuring cefixime MIC is recommended to predict treatment outcomes.
- Clinical guidelines may need updates regarding cefixime use for IPDs.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...


